Nausea in the US, EU and Canadian documents
The US label does not give one nausea figure. Section 6.1 reports injection safety from three separate groups of trials. Table 3 pools three placebo-controlled studies in adults who used 2.4 mg for up to 68 weeks (2,116 on the medicine, 1,261 on placebo; about one in five had type 2 diabetes). Table 4 comes from two 72-week studies of the 7.2 mg strength, in which adults were randomly given 7.2 mg, 2.4 mg or placebo. Table 5 covers a 68-week trial in adolescents aged 12 and older. [1]
The EU and Canadian documents add their own pools and a fact the US tables leave out: how long the episodes lasted. Read the placebo column carefully, because in every pool a sizeable share of people felt queasy with no active medicine at all.
| Source and trial pool | Placebo | Wegovy® 2.4 mg | Wegovy® 7.2 mg |
|---|---|---|---|
| US label, Table 3: adults, up to 68 weeks [1] | 16% | 44% | not in this pool |
| US label, Table 4: adults, 72 weeks [1] | 13% | 35% | 39% |
| US label, Table 5: ages 12 and older, 68 weeks [1] | 18% | 42% | not studied |
| EU SmPC section 4.8: STEP 1–4, 68 weeks [2] | 16.1% | 43.9% (“very common”); median bout 8 days | listed only for other reactions |
| Canadian monograph, Table 4: STEP 1–3 [3] | 16% | 44%; median bout 8 days | not in this monograph |
When it shows up, how long it lasts, who stopped
All three documents place digestive reactions mainly in the dose-escalation period. [1][2][3] Section 2.2 of the US label sets out the injection steps: 0.25 mg in weeks 1 to 4, then 0.5 mg, 1 mg and 1.7 mg for four weeks each, and a maintenance dose from week 17. Moving to 7.2 mg is described only for adults who have tolerated 2.4 mg for at least four weeks. If two or more weekly doses in a row are missed, section 2.4 says to restart the climb at a lower dose, again to reduce stomach reactions. [1] Each of these is a decision for your prescriber.
On duration, the EU product information and the Canadian monograph agree: most stomach and bowel events were mild to moderate and short, and the median length of a nausea episode was 8 days, against 2 days for vomiting and 3 for diarrhoea. [2][3] A median is the middle value, so some bouts were shorter and some longer.
In the adult 2.4 mg pool, 6.8% of people on Wegovy® and 3.2% on placebo stopped for good because of an adverse reaction, and nausea was the single most common reason (1.8% versus 0.2%). In the 7.2 mg studies, digestive reactions led 3% of each Wegovy® group and 0.3% of the placebo group to stop. Among teenagers, 2.3% on the medicine and 1.5% on placebo stopped because of a digestive reaction. [1]
What trial analyses and safety databases add
A manufacturer-funded analysis pooled the STEP 1–3 trials (2,117 people on semaglutide 2.4 mg, 1,262 on placebo). Almost all digestive events were non-serious (99.5%) and mild to moderate (98.1%), they were mostly temporary, and they clustered during or shortly after dose escalation. Average weight loss was similar in people who did and did not have such events, and a statistical analysis attributed less than one percentage point of the extra weight loss to them. In STEP 4, people who had already tolerated 20 weeks of the medicine continued the maintenance dose without new tolerability problems. [5]
A study of the US FDA reporting database (FAERS) for 2018 to 2022 looked at 5,442 reports of digestive problems linked to semaglutide. The median time to onset was between 6 and 23 days depending on the signal, and the pattern suggested risk fell over time. [6] Reports of this kind are sent in voluntarily, cannot give a rate and do not prove that the medicine caused the problem; they are useful mainly for timing patterns.
Why semaglutide can make you queasy
- What the label supports: semaglutide slows stomach emptying (US section 12.2), stomach reactions concentrate around dose increases, and climbing in steps is the label’s own way of lowering that risk. [1]
- Where the documents differ: the EU product information says no clinically relevant slowing of stomach emptying was seen at 2.4 mg, probably because the body adapts, while the effect of 7.2 mg on emptying was not studied. [2] Across GLP-1 medicines, a meta-analysis of scintigraphy studies measured an average delay of about 36 minutes in the time for half a meal to leave the stomach. [7] Neither source says how much of anyone’s nausea this explains.
- Proposed, not measured: the EU document notes that the GLP-1 receptor is found in brain areas that regulate appetite and that semaglutide acts there. [2] Whether the same pathways produce the queasy feeling in a given person has not been shown in the product information.
- General background, not specific to Wegovy®: MedlinePlus lists glutide-type medicines among many everyday causes of nausea, alongside stomach infections and reflux. [8]
Other possible reasons for nausea
Feeling sick while on Wegovy® is not always caused by Wegovy®. MedlinePlus lists stomach or bowel infections, food poisoning, reflux, migraine, pregnancy, motion sickness, severe pain such as kidney stones, heavy cannabis use and slow stomach emptying (gastroparesis), and warns that nausea can also be an early sign of appendicitis, a bowel blockage or an ulcer. [8] Some of these overlap with label warnings: the US label notes appendicitis in 0.5% of adults on Wegovy® versus 0.2% on placebo, and says Wegovy® is not recommended in severe gastroparesis. [1]
Pregnancy deserves its own mention. The Medication Guide asks you to tell your provider if you are pregnant or planning to be, and to stop Wegovy® two months before a planned pregnancy. [1] A new pregnancy is one reason new nausea is worth raising rather than assuming it is the medicine.
What the manufacturer and general guidance describe
Novo Nordisk’s patient page frames its suggestions as things your prescriber may recommend: bland, low-fat foods such as crackers, toast and rice; foods that contain water, such as soup and gelatin; eating more slowly; getting fresh air; and avoiding greasy food and lying down after eating. It also lists questions to ask, for example whether smaller, more frequent meals would help or how to stay hydrated without feeling too full. [4]
MedlinePlus adds that once the cause is known, sipping small amounts of clear liquids often is part of home care. [8] Anti-sickness medicines, ginger products and other remedies are not covered by the Wegovy® label; the Medication Guide asks you to tell your provider about every prescription and over-the-counter medicine, vitamin and herbal supplement you take, because Wegovy® slows stomach emptying and can affect some medicines. [1] Check with your pharmacist or prescriber before adding anything.
Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
The signs and contact information below come from this article’s sourced guidance.
Emergency
- Stomach pain that is severe and persistent, sometimes spreading to the back, whether or not you also feel sick or vomit
Contact: Stop Wegovy® and call your provider right away; emergency care if severe
Medication Guide [1]
- Blood or coffee-ground-looking material in vomit
Contact: Emergency number or emergency room
MedlinePlus [8]
- Severe nausea or vomiting after injecting more than prescribed
Contact: Your provider, Poison Help (US 1-800-222-1222) or the nearest emergency room
Medication Guide [1]
Today
- Nausea with vomiting or diarrhoea that does not go away, or signs of dehydration such as little or dark urine
Contact: Your prescriber, the same day
- Pain in the upper stomach with fever, yellow skin or eyes, or clay-coloured stools
Contact: Your prescriber
Medication Guide [1]
At your next appointment
- Nausea that bothers you or keeps returning after each dose increase
Contact: Your prescriber at the next appointment
Medication Guide [1]